PMDA drug package insert
金粒神氣心
PMDA OTC drug · 合一製薬 · package insert Mar 9, 2022
Key facts
| Brand names | 金粒神氣心 |
|---|---|
| Companies | 製造販売元／株式会社渡邊薬品,販売会社／合一製薬 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | その他 |
| OTC effect category | 強心薬（センソ含有製剤等） |
| Package insert date | Mar 9, 2022 |
| PMDA document key | 201354_K1612000001 |
| PMDA company code | 201354 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: